Biocytogen is a biotechnology company that provides gene editing and antibody discovery services to the pharmaceutical and biotech industries. The company's proprietary gene editing technology, called KNOCKOUT™, enables the creation of genetically modified animal models for drug discovery and development. Biocytogen also offers a range of antibody discovery services, including hybridoma development, antibody humanization, and antibody engineering. Biocytogen is headquartered in Burlingame, California and has additional locations in Massachusetts, New Jersey, and China.